Press release
Real-World Evidence (RWE) Solutions Market to Reach USD 6.8 Billion by 2030
Real-World Evidence (RWE) Solutions Market
Pune, India - Exactitude Consultancy publishes its latest insights on the Real-World Evidence (RWE) Solutions Market, highlighting rapid global expansion fueled by rising regulatory acceptance, adoption of real-world data (RWD) in clinical development, and increased demand for post-market surveillance. As healthcare becomes more data-driven, RWE is reshaping drug development, safety analytics, market access, and value-based care.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73721
Key Takeaways
• Market Size (2030): USD 6.8 Billion
• CAGR (2025-2030): 13.4%
• Claims & EHR data remain the largest RWD source.
• Oncology and rare disease segments show highest RWE adoption.
• North America dominates; Asia Pacific emerges as the fastest-growing region.
Market Story: Why RWE Is Becoming Central to Pharma & Healthcare Decisions
Healthcare systems generate enormous volumes of real-world data-EHRs, insurance claims, wearables, lab reports, patient registries, digital health apps, genomics data, and social determinants of health (SDoH).
RWE solutions use AI, analytics, NLP, and cloud platforms to transform this unstructured data into evidence supporting:
• Drug development & trial design
• Post-marketing safety & pharmacovigilance
• Clinical decision-making & treatment effectiveness
• Label expansion applications
• Market access & pricing negotiations
• Value-based care contracts
• Regulatory submissions (FDA, EMA, PMDA increasingly accepting RWE)
With rising interest in decentralized trials and precision medicine, RWE is becoming an indispensable tool for life sciences companies.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73721/real-world-evidence-solutions-market
Market Segments
By Component
• Real-World Data Platforms (Largest Segment)
• Analytics & Insights Tools
• Data Integration & Management Software
• Cloud & AI-Enabled RWE Platforms
• Consulting, Custom RWE Studies & Services
By Data Source
• Electronic Health Records (EHRs)
• Medical Claims & Billing Data
• Patient Registries
• Wearables & Mobile Health Data
• Genomics & Biomarker Data
• Pharmacy Data
• Social & Behavioral Health Data
By Application
• Drug Development & Early Research
• Clinical Trial Optimization
• Market Access & Pricing Strategy
• Pharmacovigilance & Safety Monitoring
• Regulatory Submissions
• Treatment Pathway Analysis
• Health Economics & Outcomes Research (HEOR)
By End User
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Healthcare Providers
• Payers & Insurance Companies
• Regulatory Agencies
• Digital Health Platforms & AI Companies
By Region
• North America - Leading adoption backed by FDA's RWE Framework
• Europe - Strong RWE initiatives under EMA & national health systems
• Asia Pacific - Fastest CAGR due to digital health expansion
• Latin America - Increasing use in epidemiology & value-based programs
• Middle East & Africa - Emerging adoption with database modernization
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73721
Recent Developments
• IQVIA launched advanced AI-driven RWE analytics for oncology & rare diseases.
• Optum expanded its integrated RWD platform for payer-provider analytics.
• Flatiron Health added new structured oncology datasets approved for regulatory use.
• TriNetX strengthened its global clinical research network for decentralized trials.
• Syneos Health & Clarivate collaborated on RWE solutions for faster drug-market access.
Expert Quote
"RWE is becoming a powerful decision-making engine across the drug lifecycle. With AI-enabled analytics and expanded regulatory acceptance, real-world evidence is driving faster development, safer therapies, and more transparent value-based care models,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Drivers
• Growing availability of large-scale real-world datasets
• Increased regulatory acceptance for RWE submissions
• High adoption of AI & NLP for unstructured data processing
• Shift toward value-based care and outcomes-based reimbursement
• Demand for post-marketing surveillance and safety reporting
• Rapid expansion of wearables & digital health platforms
Forecast Outlook (2025-2030)
With a projected 13.4% CAGR, the RWE market is set to become a mainstream component of global healthcare and pharmaceutical decision-making by 2030. Growth will be fueled by AI-driven analytics, cloud RWE ecosystems, and expanding use in clinical development and regulatory pathways.
Regional Insights
• North America:
o Strongest adoption due to FDA support and rich RWD networks.
• Europe:
o EMA expanding RWE frameworks for safety & regulatory evidence.
• Asia Pacific:
o Fastest growth, driven by digital health systems and national registries.
Conclusion
The Real-World Evidence Solutions Market is transforming the future of healthcare and drug development. From regulatory filings to safety monitoring and market access, RWE is bringing transparency, accuracy, and speed to decision-making across the life sciences industry.
This report is also available in the following languages : Japanese (リアルワールドエビデンスソリューション市場), Korean (실제 세계 증거 솔루션 시장), Chinese (真实世界证据解决方案市场), French (Marché des solutions de données probantes en situation réelle), German (Markt für Real-World-Evidence-Lösungen), and Italian (Mercato delle soluzioni di prove del mondo reale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73721
Our More Reports:
Non-Viral Transfection Reagents Market
https://exactitudeconsultancy.com/reports/73537/non-viral-transfection-reagents-market
Cell Sorting Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
Pharmaceutical Spray Drying Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
Bio/Pharmaceutical Outsourcing Market
https://exactitudeconsultancy.com/reports/73627/bio-pharmaceutical-outsourcing-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Real-World Evidence (RWE) Solutions Market to Reach USD 6.8 Billion by 2030 here
News-ID: 4296452 • Views: …
More Releases from Exactitude Consultancy
Computer-Aided Drug Discovery (CADD) Market to Reach USD 7.9 Billion by 2030
Introduction
Pune, India - Exactitude Consultancy announces new insights on the Computer-Aided Drug Discovery (CADD) Market, highlighting rapid expansion driven by AI-powered molecular design, in-silico simulation, MD (molecular dynamics), virtual screening, and structure-based drug development. As pharmaceutical R&D costs surge and timelines stretch, CADD is becoming a mission-critical technology for next-generation therapeutics.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73719
Key Takeaways
• Market Size (2030): USD 7.9 Billion
• CAGR (2025-2030): 11.6%
• Structure-based drug design (SBDD)…
AI in Clinical Trials Market to Reach USD 9.4 Billion by 2030
Introduction
Pune, India - Exactitude Consultancy releases its latest analysis on the AI in Clinical Trials Market, showcasing how artificial intelligence is fundamentally reshaping clinical development. With rising R&D costs, longer trial timelines, and increasing complexity of precision-medicine-driven studies, AI is enabling faster, smarter, and more efficient clinical research.
AI's ability to process real-world data, predict outcomes, automate patient matching, and streamline site monitoring is positioning it as a critical technology for…
AI in Medical Imaging Market to Reach USD 14.8 Billion by 2030
Introduction
Pune, India - Exactitude Consultancy releases its latest report on the AI in Medical Imaging Market, showcasing rapid global adoption of AI-powered radiology tools driven by rising imaging volumes, workforce shortages, and the need for faster and more accurate diagnostics. From cancer screening to cardiovascular assessment, AI is becoming a critical component of next-generation imaging workflows.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73715
Key Takeaways
• Market Size (2030): USD 14.8 Billion
• CAGR…
Pharma Cloud Services Market to Reach USD 18.4 Billion by 2030
Introduction
Pune, India - Exactitude Consultancy unveils its newest insights on the Pharma Cloud Services Market, revealing strong global growth driven by the rapid digitalization of pharmaceutical R&D, manufacturing, regulatory workflows, and commercial operations. As pharmaceutical firms strive for agility, cost-efficiency, and secure collaboration, cloud solutions have become essential infrastructure across the entire drug development lifecycle.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73713
Key Takeaways
• Market Size (2030): USD 18.4 Billion
• CAGR (2025-2030):…
More Releases for RWE
Wood-Pellets Market Expected to Reach Nearly USD 9.0 Billion by 2031 | RWE Innog …
QYResearch A newly published report titled "Global Wood-Pellets Market 2025 is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Wood-Pellets market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and…
U.S. Real-World Evidence (RWE) Solutions Market - Forecast to 2029
Meticulous Research®- leading U.S. market research company published a research report titled "U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029."
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5243
According to this latest publication from Meticulous Research®, the U.S. real-world evidence (RWE) solutions market is expected to grow at a CAGR of 13.1%…
Real-world Evidence (RWE) Analytics Market Worth $2.93 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'RWE Analytics Market by Application [Market Access & Reimbursement, Drug Development & Approval (Oncology, Neurology, Cardiovascular), Post Market Surveillance, Medical Device Development], End User (Pharma, Payer, Provider) - Global Forecast to 2029'.
Access Complete Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5306
According to this latest publication from Meticulous Research®, the global real-world evidence (RWE) analytics market is expected to grow…
Sales of Real World Evidence/RWE Solutions Industry by 2031 | GIS
Global Real World Evidence/RWE Solutions Market report from Global Insight Services is the single authoritative source of intelligence on Real World Evidence/RWE Solutions Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data…
Real-World Evidence (RWE) Oncology Market Worth $1.65 Billion by 2029
According to a new market research report titled, 'RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), and End User (Pharma, Payer) - Global Forecast to 2029,' published by Meticulous Research®, the real-world evidence oncology solutions market is expected to grow at a CAGR of 14.2% from 2022-2029 to reach $1.65 billion by 2029.
Download Free Sample Report…
Nuclear Power Plant Market Next Big Thing | Kepco, Magnox, RWE, Entergy
Nuclear power plant (NPP) uses nuclear fission reaction to heat water to produce steam which runs the turbines to generate electricity. The fission process occurs inside the reactor where uranium fuel is stored in its core. Considering the high fuel to output ratio produced by these power plants, countries are heavily investing in development of nuclear power plant. United States accounts for 20% of their total electricity production through nuclear…
